Jazz Pharmaceuticals (JAZZ) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.60% |
| Dec 31, 2025 | -23.62% |
| Sep 30, 2025 | 434.24% |
| Jun 30, 2025 | -79.33% |
| Mar 31, 2025 | 7.83% |
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | 20.34% |
| Jun 30, 2024 | 24.00% |
| Mar 31, 2024 | 59.69% |
| Dec 31, 2023 | -45.53% |
| Sep 30, 2023 | 3.51% |
| Jun 30, 2023 | -7.47% |
| Mar 31, 2023 | -6.22% |
| Dec 31, 2022 | -18.19% |
| Sep 30, 2022 | 37.93% |
| Jun 30, 2022 | 45.01% |
| Mar 31, 2022 | 17.57% |
| Dec 31, 2021 | -35.14% |
| Sep 30, 2021 | 557.30% |
| Jun 30, 2021 | -85.37% |
| Mar 31, 2021 | 53.00% |
| Dec 31, 2020 | -27.77% |
| Sep 30, 2020 | 41.29% |
| Jun 30, 2020 | -33.14% |
| Mar 31, 2020 | 210.91% |
| Dec 31, 2019 | -73.99% |
| Sep 30, 2019 | 126.74% |
| Jun 30, 2019 | -26.41% |
| Mar 31, 2019 | -7.26% |
| Dec 31, 2018 | -1.53% |
| Sep 30, 2018 | 15.37% |
| Jun 30, 2018 | 14.71% |
| Mar 31, 2018 | -18.19% |
| Dec 31, 2017 | 8.29% |
| Sep 30, 2017 | 39.83% |
| Jun 30, 2017 | -17.90% |
| Mar 31, 2017 | -8.94% |
| Dec 31, 2016 | 35.83% |
| Sep 30, 2016 | 4.73% |
| Jun 30, 2016 | -16.25% |
| Mar 31, 2016 | 26.65% |
| Dec 31, 2015 | -31.61% |
| Sep 30, 2015 | 24.55% |
| Jun 30, 2015 | 45.59% |
| Mar 31, 2015 | -28.08% |
| Dec 31, 2014 | 3.52% |
| Sep 30, 2014 | 73.10% |
| Jun 30, 2014 | 9.02% |
| Sep 30, 2013 | 166.38% |
| Jun 30, 2013 | 12.48% |
| Mar 31, 2013 | -33.02% |
| Dec 31, 2012 | 136.38% |
| Sep 30, 2012 | -42.65% |
| Jun 30, 2012 | 216.81% |
| Mar 31, 2012 | -44.35% |
| Dec 31, 2011 | -5.20% |
| Sep 30, 2011 | 23.02% |
| Jun 30, 2011 | 53.13% |
| Mar 31, 2011 | 7.27% |
| Dec 31, 2010 | 23.29% |